We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.6B
AUM Growth
+$48.1M
Cap. Flow
-$19.5M
Cap. Flow %
-0.75%
Top 10 Hldgs %
37.12%
Holding
232
New
10
Increased
45
Reduced
101
Closed
15
Avg Time Held
13.1 quarters
Top 10 Avg Time Held
11.5 quarters
Top 20 Avg Time Held
11.8 quarters

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$22.1M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$14.7M
3
IBM icon
IBM
IBM
+$9.86M
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$9.81M
5
ORCL icon
Oracle
ORCL
+$9.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.5M
2
PEP icon
PepsiCo
PEP
+$12.1M
3
GILD icon
Gilead Sciences
GILD
+$9.61M
4
COL
Rockwell Collins
COL
+$4.97M
5
PG icon
Procter & Gamble
PG
+$4.81M

Sector Composition

Rank Sector Weight
1 Industrials 19.66%
2 Financials 16.35%
3 Communication Services 15.88%
4 Healthcare 13.78%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PSX icon
201
Phillips 66
PSX
$114B
$231K 0.01%
2,525
-333
-12% -$28.2K
2013 Q2
17 quarters
USB icon
202
US Bancorp
USB
$88.8B
$223K 0.01%
4,165
-126
-3% -$6.59K
2016 Q4
3 quarters
DTE icon
203
DTE Energy
DTE
$26.5B
$220K 0.01%
2,409
– –
2016 Q4
3 quarters
PPH icon
204
VanEck Pharmaceutical ETF
PPH
$1.03B
$219K 0.01%
3,800
– –
2017 Q1
2 quarters
HSBC icon
205
HSBC
HSBC
$325B
$218K 0.01%
4,821
– –
2017 Q2
1 quarter
TD icon
206
Toronto Dominion Bank
TD
$192B
$218K 0.01%
+3,880
New +$204K
2017 Q3
0 quarters
MKL icon
207
Markel Group
MKL
$22.2B
$214K 0.01%
+200
New +$207K
2017 Q3
0 quarters
VVC
208
DELISTED
Vectren Corporation
VVC
$207K 0.01%
+3,147
New +$197K
2017 Q3
0 quarters
VPL icon
209
Vanguard FTSE Pacific ETF
VPL
$8.76B
$205K 0.01%
+3,000
New +$202K
2017 Q3
0 quarters
ILF icon
210
iShares Latin America 40 ETF
ILF
$4.13B
$204K 0.01%
+5,800
New +$196K
2017 Q3
0 quarters
QEP
211
DELISTED
QEP RESOURCES, INC.
QEP
$185K 0.01%
21,600
– –
2013 Q2
17 quarters
NWSA icon
212
News Corp Class A
NWSA
$15.9B
$181K 0.01%
13,640
– –
2013 Q3
16 quarters
CVE icon
213
Cenovus Energy
CVE
$60.1B
$168K 0.01%
16,792
– –
2013 Q2
17 quarters
LXRX icon
214
Lexicon Pharmaceuticals
LXRX
$725M
$167K 0.01%
13,618
– –
2013 Q2
17 quarters
AES icon
215
AES
AES
$10.7B
$123K ﹤0.01%
+11,185
New +$125K
2017 Q3
0 quarters
MDR
216
DELISTED
McDermott International
MDR
$79K ﹤0.01%
3,600
-367
-9% -$7.36K
2013 Q3
16 quarters
CFRX
217
DELISTED
ContraFect Corporation
CFRX
$17K ﹤0.01%
19
– –
2015 Q3
8 quarters
BIIB icon
218
Biogen
BIIB
$33.7B
– –
-60,947
Closed -$16.5M –
DKS icon
219
Dick's Sporting Goods
DKS
$13.4B
– –
-59,810
Closed -$2.38M –
EG icon
220
Everest Group
EG
$14.4B
– –
-1,150
Closed -$293K –
EXEL icon
221
Exelixis
EXEL
$14.8B
– –
-9,000
Closed -$222K –
IJH icon
222
iShares Core S&P Mid-Cap ETF
IJH
$122B
– –
-6,055
Closed -$211K –
KG icon
223
Kestrel Group
KG
$36.9M
– –
-535
Closed -$119K –
TEVA icon
224
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
– –
-28,120
Closed -$934K –
BBBY
225
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-7,230
Closed -$220K –

Similar funds

Klingenstein Fields & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Klingenstein Fields & Co held 232 positions worth $2.6B, up 1.9% from $2.55B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q3 2017 filing shows 10 new, 45 increased, 101 reduced and 15 closed positions. Its largest new stake was Applied Materials: 11,560 shares worth $602K. The largest sale was Biogen, an estimated $16.5M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Financials and Communication Services.

  • Klingenstein Fields & Co's largest Q3 2017 buy was Applied Materials: 11,560 shares worth $602K.
  • Klingenstein Fields & Co added most to Intel in Q3 2017, an estimated $22.1M increase.
  • Klingenstein Fields & Co's biggest Q3 2017 reduction was PepsiCo, cutting an estimated $12.1M.
  • Klingenstein Fields & Co fully exited Biogen in Q3 2017, selling an estimated $16.5M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.6B portfolio in Q3 2017.
  • Klingenstein Fields & Co opened 10 new positions and closed 15 in Q3 2017.
  • Klingenstein Fields & Co's portfolio value rose 1.9% quarter-over-quarter to $2.6B.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.